Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 347

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 1A
Chunk 347
---
Item 1A. RISK FACTORS

For information regarding factors that could affect the Company's results of operations, financial condition and liquidity, see the risk factors discussed in Part I, Item 1A - "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The following table provides information about The Cigna Group share repurchase activity for the quarter ended September 30, 2025:PeriodTotal # of shares purchased (1) Average price paid per share (1) (3)Total # of shares purchased as part ofpublicly announced program (2)Approximate dollar value of sharesthat may yet be purchased as partof publicly announced program (3) (in millions)July 1 - 31, 20251,109 $304.07 — $7,732 August 1 - 31, 20252,402 $299.23 — $7,732 September 1 - 30, 20252,989 $290.74 — $7,732 Total6,500 $296.15 — N/A

(1)Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 1,109 shares in July, 2,402 shares in August and 2,989 shares in September 2025. 

(2)Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date.

(3)The average price paid per share and approximate dollar value